Citadel Advisors’s GE HealthCare GEHC Stock Holding History

Citadel Advisors’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$55.5M	Buy	780,000 +454,500	+140%	+$35.8M	0.01%	1266
2025 Q4	$26.7M	Sell	325,500 -2,900	-0.9%	-$226K	﹤0.01%	2038
2025 Q3	$24.7M	Buy	328,400 +48,400	+17%	+$3.61M	﹤0.01%	2072
2025 Q2	$20.7M	Sell	280,000 -803,900	-74%	-$56M	﹤0.01%	2097
2025 Q1	$87.5M	Buy	1,083,900 +663,230	+158%	+$57M	0.02%	772
2024 Q4	$32.9M	Sell	420,670 -403,900	-49%	-$34.3M	0.01%	1652
2024 Q3	$77.4M	Buy	824,570 +178,700	+28%	+$15M	0.01%	886
2024 Q2	$50.3M	Sell	645,870 -188,698	-23%	-$15.4M	0.01%	1142
2024 Q1	$75.9M	Sell	834,568 -190,066	-19%	-$15.8M	0.01%	903
2023 Q4	$79.2M	Sell	1,024,634 -98,042	-9%	-$6.87M	0.02%	834
2023 Q3	$76.4M	Buy	1,122,676 +327,126	+41%	+$23.8M	0.02%	779
2023 Q2	$64.6M	Buy	795,550 +96,660	+14%	+$7.71M	0.01%	862
2023 Q1	$57.3M	Buy	+698,890	New	+$49.9M	0.01%	963

Other funds holding GEHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Citadel Advisors's GEHC Position: Q1 2026 in Review

Citadel Advisors increased its GE HealthCare (GEHC) stake by 244% in Q1 2026, buying an estimated $72.3M and bringing the position to 1,293,268 shares worth $92.1M. The position accounts for 0.01% of the portfolio, ranked #871.

Citadel Advisors first reported a position in GEHC in Q4 2022 and has held it in 14 quarters since. The position peaked at $689M in Q2 2025. 1,265 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

Citadel Advisors held 1,293,268 shares of GE HealthCare worth $92.1M as of Q1 2026.
Citadel Advisors bought 917,266 GE HealthCare shares in Q1 2026, an estimated $72.3M.
GE HealthCare made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #871 holding.
Citadel Advisors first reported a position in GE HealthCare in Q4 2022 and has held it in 14 quarters since.
Citadel Advisors's GE HealthCare position peaked at $689M in Q2 2025.
1,265 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.